Investing.com - Palatin reported on Monday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Palatin announced earnings per share of $-0.8600 on revenue of $870K. Analysts polled by Investing.com EPS of $-0.5800 on revenue of $211K.
Palatin 's are down 19.03% and is trading at $5.0400 , still down 80.54% from its 52 week high of $24.00 set on Monday, November 29, 2021.
Palatin shares gained 7.92% to trade at $5.0400 in pre-market trade the report.
Palatin follows other major Healthcare sector earnings this month
Palatin's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar